Kayne Anderson Rudnick Investment Management’s Outset Medical OM Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66	Closed	-$245	–	1014
2025 Q4	$245	Hold	66	–	–	﹤0.01%	981
2025 Q3	$932	Hold	66	–	–	﹤0.01%	887
2025 Q2	$1.27K	Hold	66	–	–	﹤0.01%	904
2025 Q1	$730	Sell	66 -1	-1%	-$12	﹤0.01%	881
2024 Q4	$1.11K	Hold	67	–	–	﹤0.01%	876
2024 Q3	$677	Hold	67	–	–	﹤0.01%	914
2024 Q2	$3.85K	Hold	67	–	–	﹤0.01%	700
2024 Q1	$2.22K	Hold	67	–	–	﹤0.01%	756
2023 Q4	$5.41K	Hold	67	–	–	﹤0.01%	660
2023 Q3	$10.9K	Hold	67	–	–	﹤0.01%	585
2023 Q2	$21.9K	Hold	67	–	–	﹤0.01%	554
2023 Q1	$18.4K	Hold	67	–	–	﹤0.01%	547
2022 Q4	$25.8K	Buy	+67	New	+$18.9K	﹤0.01%	542

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's OM Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management sold out of Outset Medical (OM) in Q1 2026, closing a stake of 66 shares — an estimated $245 sold.

Kayne Anderson Rudnick Investment Management first reported a position in OM in Q4 2022 and held it in 13 quarters. The position peaked at $25.8K in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Kayne Anderson Rudnick Investment Management reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
Kayne Anderson Rudnick Investment Management sold 66 Outset Medical shares in Q1 2026, an estimated $245.
Kayne Anderson Rudnick Investment Management first reported a position in Outset Medical in Q4 2022 and held it in 13 quarters.
Kayne Anderson Rudnick Investment Management's Outset Medical position peaked at $25.8K in Q4 2022.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.